 
                                                                                                    08/09/2025
                                            ⚠️ Could your weight loss shot cost you your eyesight?
A shocking new study links Ozempic and other semaglutide drugs (Wegovy, Rybelsus) with a rare but devastating complication: sudden, painless, and irreversible vision loss (NAION).
📊 Facts you need to know:
* Risk of NAION is 7x higher in patients taking semaglutide (JAMA, 2024).
* EMA & WHO added blindness warning to Ozempic instructions (Summer 2025).
* Over 1,800 lawsuits already filed in the US against Novo Nordisk.
* Potential payouts: $1M per case.
* FDA may issue a black box warning — the strictest level of drug warning.
💡 At BioCell Clinic in Lagos, Nigeria, we bring you the latest medical updates — not to spread fear, but to help you make informed, safe, and responsible choices about your health.
✨ Remember: The future of longevity is not a “magic pill” — it’s a partnership of knowledge, responsibility, and wise decisions.
Would you still take Ozempic after knowing this? Share your thoughts in a comment 👇
❤️ And share with those who need to know this…
                                                 
 
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                         
   
   
   
   
     
   
   
  